Clinical Trials Logo

Adult clinical trials

View clinical trials related to Adult.

Filter by:

NCT ID: NCT02213705 Completed - ADULT Clinical Trials

Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells

MSC
Start date: May 6, 2014
Phase: Phase 1/Phase 2
Study type: Interventional

The main ailm of this phase I-II study is to evaluate toxicity and efficacy of allogenic mesenchymal stem cell therapy to treat severe systemic sclerosis. In practice this treatment will be given to patients with a rapidly evolutive disease or refractory to cyclophosphamide.

NCT ID: NCT02195778 Active, not recruiting - Adult Clinical Trials

Assessment of Health Literacy Among Adult Patients in the United Arab Emirates to Facilitate Clinical Trials Recruitment.

LIT
Start date: June 2013
Phase: N/A
Study type: Observational [Patient Registry]

Health Literacy is the ability to understand health information and to use that information to make good decisions about health and medical care. Health informatin can overwhelm even people with advanced literacy skills. About one third of the adult population in the United States has limited health literacy.

NCT ID: NCT02147392 Completed - Pharmacokinetics Clinical Trials

Assessment of [11C]ER176 to Image Translocator Protein in Brain and Whole Body of Healthy People

Start date: May 14, 2014
Phase: Early Phase 1
Study type: Interventional

Background: - A protein called translocator protein may play a role in brain inflammation. Sometimes it is present at higher levels in the lungs than in the brain. Researchers want to see if a drug called [11C]ER176 can provide an image of this protein in the brain. Objective: - To test the ability of a drug to image a protein, and test how it is distributed in the body. Eligibility: - Healthy adults over age 18. Design: - Participants will be screened with medical history, physical exam, and blood and urine tests. - Participants will have a PET scan of the brain using [11C]ER176. It will be injected through an intravenous tube into 1-2 arm veins. A tube may also be put into an artery at the wrist or elbow. Some participants will also have a lung scan. - For the PET, participants will lie on a bed that slides in and out of a doughnut-shaped scanner. A plastic mask will be molded to their face and head. They may be wrapped with restraining sheets. The scan will last about 120 minutes. Blood may be taken during the scan. - Blood and urine will be taken before and after the scan. - During another visit, participants will have an MRI scan of the brain. Participants will lie on a table that slides in and out of a metal cylinder. A strong magnetic field and radio waves will take pictures of the brain. The scanner makes loud knocking noises. Participants will be given earplugs. - Some participants will have only a whole-body PET scan using [11C]ER176.

NCT ID: NCT01943565 Not yet recruiting - Healthy Clinical Trials

Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study

Start date: October 2013
Phase: Phase 4
Study type: Interventional

Pain relief after cesarean delivery can be provided in a few ways. Most commonly, certain medications called opioids, such as morphine, are given through the vein or into the muscle. However, a more effective way to give pain relief with fewer side effects (such as nausea and slowing your breathing) is to give opioids in the spinal space as part of the medications given for a cesarean delivery. For many years, the opioid of choice was morphine due to its long anesthetic effect and acceptable side effect profile. A nation-wide disruption in the supply of preservative-free morphine has made it necessary to look for alternatives. Many institutions worldwide have used another opioid, called hydromorphone, in the spinal space for over a decade. This drug has a very good safety and side effect profile and has been used at our institution for more than a year. Of interest, while a number of different doses of hydromorphone have been used, there have been very few studies to evaluate the best dose for providing good pain relief with minimal side effects. The goal of this study is to find the best dose of spinal hydromorphone for women undergoing cesarean delivery.

NCT ID: NCT01939925 Completed - Adult Clinical Trials

Communicating Evidence From Systematic Reviews to the Public

PLSRCT
Start date: May 2009
Phase: N/A
Study type: Interventional

The purpose of this randomised controlled trial is to compare a new standardised summary format for presentation of synthesised evidence from systematic reviews for the public (a new plain language summary format) to the current format used in Cochrane systematic reviews. The study will evaluate if the new presentation improves understanding about the benefits and harms of an intervention, if it improves the accessibility of the information, and if it is preferred over other versions by the public over the current format.

NCT ID: NCT01915719 Completed - Adult Clinical Trials

Early Non Invasive Ventilation in Immuno-compromized Patients With Acute Respiratory Failure.

IVNICTUS
Start date: August 2013
Phase: N/A
Study type: Interventional

Assess the superiority of early non invasive ventilation in comparison to Oxygen therapy only, for immuno-compromized patients with acute respiratory failure

NCT ID: NCT01817153 Terminated - Septic Shock Clinical Trials

Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.

HyStOON
Start date: November 5, 2013
Phase: Phase 2/Phase 3
Study type: Interventional

The main objectives of the study are 1)to examine the immediate (2 hours) and delayed (8 hours) effects of intravenous hydrocortison on macro and microvascular post-ischemic vasoreactivity, in septic shock adult patients; 2) to examine possible correlations between post-ischemic flow-mediated dilation (FMD) of the brachial artery (assessed by ultrasound imaging) and post-ischemic recovery slope of the thenar oxygen saturation (StO2) (assessed by near-infrared spectroscopy).

NCT ID: NCT01593280 Recruiting - Cesarean Section Clinical Trials

TAP Catheters Versus Intrathecal Morphine for Cesarean Section

Start date: May 2012
Phase: N/A
Study type: Interventional

Morphine, when given as part of spinal anesthesia, is associated high incidence of nausea and pruritus, which may affect quality of recovery. The investigators hypothesize that long-acting local anesthetic infusions via TAP catheter can provide better quality of recovery after cesarean section than spinal morphine.

NCT ID: NCT01589796 Recruiting - Adult Clinical Trials

Medial Versus Traditional Approach to US-guided TAP Blocks for Open Inguinal Hernia Repair

Start date: April 2012
Phase: N/A
Study type: Interventional

Pain relief after open inguinal hernia repair could be improved by administration of TAP block or ilioinguinal/iliohypogastric nerve block. It is unclear which one works better. The investigators hypothesize that doing TAP block closer to the middle of the abdomen would result in improved pain relief due to simultaneous block of ilioinguinal/iliohypogastric nerves.

NCT ID: NCT01570465 Terminated - AML Clinical Trials

Prospective Study on Severe Infections on Acute Myeloid Leukemia (AML) Patients

AML1411
Start date: September 11, 2012
Phase:
Study type: Observational

All patients receiving induction, consolidation and salvage chemotherapy, and autologous or allogeneic stem cell transplantation according to a strategy defined in the GIMEMA AML1310 protocol will be prospectively monitored for SI (bacteremia, invasive mycoses, other microbiologically documented bacterial infections, pneumonia, other invasive tissue infections and viral diseases) during each chemotherapy and transplant and the impact of these infections on survival will be evaluated until 24 months from the diagnosis of AML.